MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Hill-Rom to acquire Voalte for $195m

Hill-Rom to acquire Voalte for $195m

By

Hill-Rom, Voalte

Hill-Rom Holdings (NYSE:HRC) said yesterday that it inked a deal to acquire mobile healthcare communications developer Voalte in a deal worth up to $195 million.

Through the deal, Chicago-based Hill-Rom will pay a cash consideration of $180 million and up to an additional $15 million in milestone-based payments.

Hill-Rom said that the acquisition of Sarasota, Fla.-based Voalte, which was founded in 2008 and recently reported yearly revenue of nearly $40 million, will advance its digital and mobile communications platform and capabilities.

Voalte currently serves more than 200 healthcare customers with more than 84,000 devices on its mobile platform, connecting approximately 220,000 caregivers and providing voice, alarm and text communications.

“Our scalable enterprise communication platform is proving to be a critical tool in the digital transformation of healthcare systems, and we look forward to further developing our platform in alignment with Hill-Rom’s vision of advancing connected care. Bringing our companies together will allow us to offer customers a single, integrated solution – delivering actionable data from smart hospital beds, nurse call and patient monitoring technology right to a caregiver’s mobile device,” Voalte CEO Trey Lauderdale said in a press release.

Hill-Rom said that it expects the deal to close during its fiscal third quarter of this year, and that it expects the acquisition to be modestly dilutive to its adjusted earnings per diluted share for its fiscal year 2019 and increasingly accretive in its fiscal year 2020 and beyond. The company added that it does not expect the deal to have a material impact on its fiscal 2019 adjusted earnings guidance.

“Interoperability and connectivity have become critical elements in providing quality healthcare, reducing length of stay and driving efficiencies across the healthcare continuum. This transaction strategically fits with our vision of advancing connected care to improve workflow and real-time actionable insights at the point of care, while driving accelerated growth and delivering an attractive margin profile. We look forward to welcoming and working closely with the talented Voalte team, and benefiting from Voalte’s technology, capabilities and substantial installed customer base to enhance outcomes for patients and their caregivers,” Hill-Rom prez & CEO John Groetelaars said in a prepared statement.

In January, Hill-Rom reported fiscal second-quarter results that beat the consensus forecast on Wall Street.

In case you missed it

RSS From Medical Design & Outsourcing

  • Tegra Medical announces new director of sales and marketing in Europe
    Tegra Medical announced that it appointed Darren Vine as its director of sales and marketing in Europe. Franklin, Mass.-based Tegra said in a news release that Vine will report to CEO and head of SFS division medical Walter Kobler, with responsibilities including the building of the company’s presence through expansion into new markets around the… […]
  • 5 challenges Boston Scientific overcame to make single-use scopes work
    FDA wanted single-use scopes to reduce potentially deadly superbug infections. Here’s how Boston Scientific made it happen. Boston Scientific’s Exalt Model D Single-Use Duodenoscope received FDA clearance in December 2019. It was the first device of its kind to hit the medical market. Just five months earlier, the FDA urged device manufacturers to move away from re-usable duodenoscopes with… […]
  • Veranex acquires Experien Group
    Veranex announced today that it acquired Experien Group, a provider of regulatory, quality and clinical consulting services for medtech companies. Raleigh, N.C.-based Veranex, which was created as a combination of companies after Summit Partners acquired Ximedica, Quartesian and Boston Healthcare Associates in June, offers integrated product development strategies and services to medtech companies. According to… […]
  • How Olympus is using AI to find patients for its COPD device
    Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen which people might benefit from its Spiration valve system. Spiration is an FDA-designated breakthrough device for treating chronic obstructive pulmonary disease (COPD) patients. SeleCT Connect — offered as part of Olympus’ SeleCT quantitative computer tomography (QCT) analysis service — is… […]
  • Catheter & Medical Design and VitalDyne Medical rebrand as VitalPath
    Catheter & Medical Design and VitalDyne Medical — makers of complex medical catheter systems — have rebranded under the name VitalPath. The move comes about five months after CMD’s March 2021 acquisition of VitalDyne. The Roseville, Minn.–based company also has a new website at vitalpath.com. VitalPath will exhibit at booth  No. 1714 at MD&M West,… […]
  • Dymax touts newest formulations for medtech wearables
    Dymax is using MD&M West in Anaheim, Calif. next week to tout its newest formulations for assembling medical device wearables. The Dymax materials are free from IBOA and TPO, are compatible with common and difficult substrates, and have passed ISO 10993-10 for sensitization and irritation, according to the Torrington, Conn.–based company. For manufacturers involved with… […]
  • What is a proportional isolation valve?
    A “proportional” isolation valve can bring the next level of control and design for engineers, especially in life science industries. Doug Paynter, Clippard When we talk about proportional valves, whether they are pneumatic or hydraulic, we typically refer to valves that vary their flow path when you apply an increasing or decreasing amount of power/current… […]
  • CoorsTek scores EU legal win in pink components trademark dispute
    The EU Trademark Court of Appeals in Paris recently upheld a Paris EU Trademark High Court decision that sided with CoorsTek against CeramTec in a trademark dispute over “pink” ceramic hip components. The Paris Court of Appeals in its June 2021 ruling upheld the cancelations of the three EU trademarks and the dismissal of CeramTec’s… […]
  • Abbott CMO Dr. Nick West touts latest iteration of drug-eluting stent
    Abbott executive Dr. Nick West believes the company offers the “best-in-class” drug-eluting stent with its Xience platform. When Abbott (NYSE:ABT) CMO & divisional VP of global medical affairs Dr. Nick West looks back at his use of drug-eluting stents in the early 2000s, all he sees now is innovation. As a practicing interventional cardiologist, West remembers… […]
  • Versapor® RC Membranes: The next generation of venting materials
    As the world leader in the design and production of membranes, filtration devices, and separation systems, Pall Corporation supplies products to nearly every industry in the world. Founded in 1946, Pall Corporation has set the standard for filtration solutions for 75 years and counting. Our customers have relied on us for their most sophisticated applications… […]
  • Tips to help bring your medical device from mind to market
    By Bret Ludwig, Ph.D. Senior Product Development Specialist, 3M Medical Materials & Technologies Great medical devices start with an idea—a spark. And from there, it might move to the back of a napkin or a notepad. But as development continues, the process can get trickier and more complex. In fact, turning an idea into a… […]